Effect of Laughter Therapy on Depression among Middle-Aged Women: A Systematic Review and Meta-Analysis
Abstract
Background: Laughter therapy, known for its health benefits, has become a popular treatment for psychological conditions such as depression over the last ten years. The effectiveness of laughter therapy may differ with the cause of depression and the age of patients. No systematic reviews or meta-analyses have focused on the impact of laughter therapy on middle-aged women's depression. This study aimed to evaluate the effect of laughter therapy on depression in middle-aged women.
Methods: Randomized controlled trials (RCTs) or quasi-experimental studies on laughter therapy were included in this systematic review and meta-analysis which compared to the control group. The systematic review included English and non-English articles that were searched in CINAHL, MEDLINE, Cochrane Library, and EMBASE electronic databases. Search terms included laugh, qigong, laughter therapy, humor, yoga, intervention, depression, middle age, menopause, and women. The article screening process was conducted by four authors independently and finally agreed upon by all. This systematic review and meta-analysis were reported according to the PRISMA guidelines. JBI critical appraisal tools were used to assess the quality of inclusion studies. The risk of bias was assessed using the risk of bias in non-randomized studies – of Interventions (ROBINS-I) assessment tool.
Results: A total of 3102 studies were examined, and two publications (two quasi-experimental studies) were included. Studies were included and evaluated by the inclusion and exclusion criteria. The results indicated a significant decrease in depression among middle-aged women.
Conclusion: Laughter therapy demonstrated cost-effectiveness and exhibited no adverse effects in middle-aged women, making it a viable option for promoting health and reducing depression among middle-aged women.
Keywords: Laughter Therapy; Depression; Middle-Aged Women; Meta-Analysis
Full Text:
PDFReferences
Abdullah M, Khan MI, Mumtaz F, Shah F, Ximenes RC, Nikoui V, et al. Risk factors associated with relapse of drug dependence after treatment and rehabilitation in areas under the influence of war on terror. Advancements in Life Sciences, (2020); 7(3) :117–121.
Mimura M. Comorbidity of depression and other diseases. Japan Medical Association Journal. (2001); 5(44): 225–229.
World Health Organization. (2021). Depressive disorder (depression) [Internet]. https://www.who.int/news-room/fact-sheets/detail/depression. [Accessed: 2022 October 23].
Barry LC, Allore HG, Guo Z, Bruce ML, Gill TM. Higher burden of depression among older women: the effect of onset, persistence, and mortality over time. Archives of General Psychiatry, (2008); 65(2): 172–178.
Barth C, Villringer A, Sacher J. Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Frontiers in Neuroscience, (2015); 9(37): 1-20.
Sassarini DJ. Depression in midlife women. Maturitas, (2016); 94: 149–154.
Prakapenka AV, Bimonte-Nelson HA. Memory and menopause: an unsolved puzzle. Aging, (2018); 10(10): 2541–2543.
Bromberger JT, Epperson CN. Depression during and after the perimenopause: Impact of hormones, genetics, and environmental determinants of disease. Obstetrics and Gynecology Clinics of North America., (2018); 45(4): 663–678.
Llaneza P, García-Portilla MP, Llaneza-Suárez D, Armott B, Pérez-López FR. Depressive disorders and the menopause transition. Maturitas, (2012); 71(2): 120–130.
Dennerstein L, Soares CN. The unique challenges of managing depression in mid-life women. World Psychiatry, (2008); 7(3): 137–142.
Karanth L, Chuni N, Nair NS. Antidepressants for menopausal symptoms. Cochrane Database of Systematic Reviews, (2019); (9): CD013417.
Sim K, Lau WK, Sim J, Sum MY, Baldessarini RJ. Prevention of relapse and recurrence in adults with major depressive disorder: Systematic review and meta-analyses of controlled trials. International Journal of Neuropsychopharmacology, (2015); 19(2): pyv076.
Craft LL, Perna FM. The benefits of exercise for the clinically depressed. Primary Care Companion to the Journal of Clinical Psychiatry, (2004); 6(3): 104–111.
Brunoni AR, Sampaio-Junior B, Moffa AH, Aparício LV, Gordon P, Klein I, et al. Noninvasive brain stimulation in psychiatric disorders: a primer. Brazilian Journal of Psychiatry, (2019); 41(1): 70–81.
Ekong MB, Iniodu CF. Nutritional therapy can reduce the burden of depression management in low income countries: A review. IBRO Neuroscience Reports, (2021); 11: 15–28.
Yim J. Therapeutic benefits of laughter in mental health: A theoretical review. The Tohoku Journal of Experimental Medicine, (2016); 239(3): 243–249.
Newland JA. Laughter is the best medicine. The Nurse Practitioner, (2020); 45(7): 6.
Mora-Ripoll R. The therapeutic value of laughter in medicine. Alternative Therapies in Health and Medicine, (2010);16(6): 56–64.
Cha MY, Na YK, Hong HS. An effect of optimism, self-esteem and depression on laughter therapy of menopausal women. Korean Journal of Women Health Nursing, (2012); 18(4): 248–256.
Cha MY, Hong HS. Effect and path analysis of laughter therapy on serotonin, depression and quality of life in middle-aged women. Journal of Korean Academy of Nursing, (2015); 45(2): 221–230.
Merriam-webster. Definition of DEPRESSION [Internet]. https://www.merriam-webster.com/dictionary/depression. [Accessed: 2022 October 23].
Ko HJ, Youn CH. Effects of laughter therapy on depression, cognition and sleep among the community-dwelling elderly. Geriatrics and Gerontology International, (2011); 11(3): 267–274.
Kim SH, Kim YH, Kim HJ, Lee SH, Yu SO. The effect of laughter therapy on depression, anxiety, and stress in patients with breast cancer undergoing radiotherapy. Asian Oncology Nursing, (2009); 9(2):
–162.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal, (2003); 327(7414):557–560.
Huang R, Wang K, Hu J. Effect of probiotics on depression: A systematic review and meta-analysis of randomized controlled trials. Nutrients, (2016); 8(8): 483.
van der Wal CN, Kok RN. Laughter-inducing therapies: Systematic review and meta-analysis. Social Science and Medicine, (2019); 232: 473–488.
Amaki M, Kamide K, Takiuchi S, Niizuma S, Horio T, Kawano Y. A case of neurally mediated syncope induced by laughter successfully treated with combination of propranolol and midodrine. International Heart Journal, (2007); 48(1): 123–127.
Braga SS, Manni R, Pedretti RFE. Laughter-induced syncope. The Lancet, (2005); 366(9483): 426.
DOI: http://dx.doi.org/10.62940/als.v11i1.1707
Refbacks
- There are currently no refbacks.